Registered number: 08407852 

**HEALTHWATCH ISLINGTON DIRECTORS' REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024** 

D S Burge and Co Ltd 



## **Healthwatch Islington Directors' Report and Unaudited Financial Statements For The Year Ended 31 March 2024** 

|**Contents**||
|---|---|
||**Page**|
|Company Information|1|
|Directors' Report|2|
|Accountant's Report|3|
|Income and Expenditure Account|4|
|Balance Sheet|5|
|Notes to the Financial Statements|6—7|
|The following pages do not form part of the statutory accounts:||
|Detailed Income and Expenditure Account|8|





**Healthwatch Islington Company Information For The Year Ended 31 March 2024** 

|**Directors**|Mr Ralph Hughes|
|---|---|
||Mr Ewan MacLeod|
||Ms Kate Overall|
||Ms Chloe Wright|
||Mr Owen O'Sullivan|
||Miss Charlotte Sivanathan|
||Mr Nathan Allcott-Watson|
||Mr Stephen Adjaidoo|
|**Secretary**|Ms Emma Whitby|
|**Company Number**|08407852|
|**Registered Office**|6-9 Manor Gardens|
||London|
||N7 6LA|
|**Accountants**|D S Burge and Co Ltd|
||Chartered Accountants|
||23 Chiltern Drive|
||Surbiton|
||Surrey|
||KT5 8LP|



Page 1 



## **Healthwatch Islington Company No. 08407852 Directors' Report For The Year Ended 31 March 2024** 

The directors present their report and the financial statements for the year ended 31 March 2024. 

## **Directors** 

The directors who held office during the year were as follows: 

Mr Ralph Hughes 

Mr Ewan MacLeod 

Ms Kate Overall 

Ms Chloe Wright 

Mr Owen O'Sullivan 

Miss Charlotte Sivanathan 

Mr Nathan Allcott-Watson 

Mr Stephen Adjaidoo Appointed 13/09/2023 

## **Statement of Directors' Responsibilities** 

The directors are responsible for preparing the Directors' Report and the financial statements in accordance with applicable law and regulations. 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the surplus or deficit of the company for that period. In preparing the financial statements the directors are required to: 

- select suitable accounting policies and then apply them consistently; 

make judgments and accounting estimates that are reasonable and prudent; 

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. 

The directors are responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions. 

## **Small Company Rules** 

This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006. 

On behalf of the board 

Mr Ewan MacLeod 

Director 

17/12/2024 

Page 2 



## **Healthwatch Islington Accountant's Report For The Year Ended 31 March 2024** 

## **Chartered Accountant's report to the directors on the preparation of the unaudited statutory accounts of Healthwatch Islington for the year ended 31 March 2024** 

In order to assist you to fulfil your duties under the Companies Act 2006, I have prepared for your approval the accounts of Healthwatch Islington for the year ended 31 March 2024 which comprise the Income and Expenditure Account, the Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given to us. 

As a practising member of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/en/membership/regulations-standards-andguidance. 

This report is made solely to the directors of Healthwatch Islington, as a body, in accordance with the terms of our engagement letter dated . Our work has been undertaken solely to prepare for your approval the accounts of Healthwatch Islington and state those matters that we have agreed to state to the directors of Healthwatch Islington, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Healthwatch Islington and its directors, as a body, for our work or for this report. 

It is your duty to ensure that Healthwatch Islington has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit or loss of Healthwatch Islington. You consider that Healthwatch Islington is exempt from the statutory audit requirement for the year. 

We have not been instructed to carry out an audit of the accounts of Healthwatch Islington. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the financial statements. 

Signed 

## 26/04/2024 

D S Burge and Co Ltd Chartered Accountants 23 Chiltern Drive Surbiton Surrey KT5 8LP 

Page 3 



## **Healthwatch Islington Income and Expenditure Account For The Year Ended 31 March 2024** 

|**Notes**<br>**TURNOVER**<br>Cost of sales<br>**GROSS SURPLUS**<br>Administrative expenses<br>**OPERATING SURPLUS**<br>Other interest receivable and similar income<br>**SURPLUS FOR THE FINANCIAL YEAR**|**2024**<br>**£**<br>604,074<br>(93,793)<br>510,281<br>(381,356)<br>128,925<br>2,517<br>131,442|**2023**<br>**£**<br>497,243<br>(157,946)|
|---|---|---|
|||339,297<br>(266,757)|
|||72,540<br>769|
|||73,309|



The notes on pages 6 to 7 form part of these financial statements. 

Page 4 



## **Healthwatch Islington Balance Sheet As At 31 March 2024** 

|**Notes**<br>**FIXED ASSETS**<br>Tangible Assets<br>**4**<br>**CURRENT ASSETS**<br>Debtors<br>**5**<br>Cash at bank and in hand<br>**Creditors: Amounts Falling Due Within**<br>**One Year**<br>**6**<br>**NET CURRENT ASSETS (LIABILITIES)**<br>**TOTAL ASSETS LESS CURRENT**<br>**LIABILITIES**<br>**NET ASSETS**<br>Income and Expenditure Account<br>**MEMBERS' FUNDS**|**2024**<br>**£**<br>**£**<br>7,540<br>7,540<br>138,100<br>402,388<br>540,488<br>(208,607)<br>331,881<br>339,421<br>339,421<br>339,421<br>339,421|**2024**<br>**£**<br>**£**<br>7,540<br>7,540<br>138,100<br>402,388<br>540,488<br>(208,607)<br>331,881<br>339,421<br>339,421<br>339,421<br>339,421|**2023**<br>**£**<br>**£**<br>3,059<br>3,059<br>11,974<br>206,613<br>218,587<br>(13,667)<br>204,920<br>207,979<br>207,979<br>207,979<br>207,979|**2023**<br>**£**<br>**£**<br>3,059<br>3,059<br>11,974<br>206,613<br>218,587<br>(13,667)<br>204,920<br>207,979<br>207,979<br>207,979<br>207,979|
|---|---|---|---|---|
|||7,540<br>331,881||3,059<br>204,920|
||540,488<br>(208,607)||218,587<br>(13,667)||
||||||
|||339,421||207,979|
|||339,421||207,979|
|||339,421||207,979|
|||339,421||207,979|



For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. 

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. 

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime. 

On behalf of the board 

Mr Ewan MacLeod 

Director 

17/12/2024 

The notes on pages 6 to 7 form part of these financial statements. 

Page 5 



**Healthwatch Islington Notes to the Financial Statements For The Year Ended 31 March 2024** 

## 1. **General Information** 

Healthwatch Islington is a private company, limited by guarantee, incorporated in England & Wales, registered number 08407852. The registered office is 6-9 Manor Gardens, London, N7 6LA. 

## 2. **Accounting Policies** 

## 2.1. **Basis of Preparation of Financial Statements** 

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. 

## 2.2. **Turnover** 

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances. 

## **Sale of goods** 

Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods. 

## **Rendering of services** 

Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably. 

## 2.3. **Tangible Fixed Assets and Depreciation** 

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases: 

|Fixtures & Fittings|4 Years|
|---|---|
|Computer Equipment|4 Years|



## 3. **Average Number of Employees** 

Average number of employees, including directors, during the year was: 12 (2023: 7) 

## 4. **Tangible Assets** 

|**Cost**<br>As at 1 April 2023<br>Additions<br>As at 31 March 2024<br>**Depreciation**<br>As at 1 April 2023<br>Provided during the period<br>As at 31 March 2024<br>**Net Book Value**<br>As at 31 March 2024<br>As at 1 April 2023|**Fixtures &**<br>**Fittings**<br>**£**<br>2,319<br>3,610|**Computer**<br>**Equipment**<br>**£**<br>6,287<br>3,939|**Total**<br>**£**<br>8,606<br>7,549|
|---|---|---|---|
||5,929|10,226|16,155|
||926<br>1,528|4,621<br>1,540|5,547<br>3,068|
||2,454|6,161|8,615|
||3,475|4,065|7,540|
||1,393|1,666|3,059|



Page 6 



## **Healthwatch Islington Notes to the Financial Statements (continued) For The Year Ended 31 March 2024** 

## 5. **Debtors** 

|.<br>**Debtors**|||
|---|---|---|
|**Due within one year**<br>Trade debtors<br>Prepayments and accrued income<br>Net wages<br>.<br>**Creditors: Amounts Falling Due Within One Year**<br>Other taxes and social security<br>Net wages<br>Other creditors<br>Accruals and deferred income|**2024**<br>**£**<br>115,600<br>22,500<br>-<br>138,100<br>**2024**<br>**£**<br>1,286<br>36<br>5,341<br>201,944<br>208,607|**2023**<br>**£**<br>-<br>11,855<br>119|
|||11,974|
|||**2023**<br>**£**<br>1,529<br>-<br>7,251<br>4,887|
|||13,667|



6. **Creditors: Amounts Falling Due Within One Year** 

## 7. **Company limited by guarantee** 

The company is limited by guarantee and has no share capital. 

Every member of the company undertakes to contribute to the assets of the company, in the event of a winding up, such an amount as may be required not exceeding £1. 

Page 7 



## **Healthwatch Islington Detailed Income and Expenditure Account For The Year Ended 31 March 2024** 

|**TURNOVER**<br>Sales<br>Other trading income<br>**COST OF SALES**<br>Purchases<br>Subcontractor costs<br>Other direct costs|**2024**<br>**£**<br>**£**<br>598,627<br>5,447<br>604,074<br>197<br>85,785<br>7,811|**2024**<br>**£**<br>**£**<br>598,627<br>5,447<br>604,074<br>197<br>85,785<br>7,811|**2023**<br>**£**<br>**£**<br>497,243<br>-<br>497,243<br>-<br>155,786<br>2,160|**2023**<br>**£**<br>**£**<br>497,243<br>-<br>497,243<br>-<br>155,786<br>2,160|
|---|---|---|---|---|
|||604,074||497,243|
|**GROSS SURPLUS**<br>**Administrative Expenses**<br>Wages and salaries<br>Employers NI<br>Employers pensions - defined contributions scheme<br>Recruitment costs<br>Volunteer training and expenses<br>Staff training<br>Travel and subsistence expenses<br>Volunteer recognition<br>Rent<br>Rates<br>Cleaning<br>Computer software, consumables and maintenance<br>Insurance<br>Printing, postage and stationery<br>Advertising and marketing costs<br>Telecommunications and data costs<br>Accountancy fees<br>Legal fees<br>Consultancy fees<br>Bank charges<br>Depreciation<br>Sundry expenses<br>**OPERATING SURPLUS**<br>**Other interest receivable and similar income**<br>Bank interest receivable<br>**SURPLUS FOR THE FINANCIAL YEAR**|290,682<br>22,062<br>13,334<br>3,707<br>477<br>3,928<br>339<br>300<br>19,533<br>334<br>-<br>3,961<br>2,571<br>203<br>6,360<br>3,437<br>5,328<br>845<br>-<br>184<br>3,068<br>703|(93,793)|210,555<br>16,131<br>10,458<br>359<br>678<br>634<br>168<br>1,002<br>6,763<br>-<br>162<br>3,596<br>1,590<br>549<br>3,789<br>3,037<br>3,576<br>335<br>2,050<br>153<br>1,090<br>82|(157,946)|
|||510,281<br>(381,356)||339,297<br>(266,757)|
||2,517||769||
|||128,925<br>2,517||72,540<br>769|
||||||
|||131,442||73,309|



Page 8 

